Eosinophilic Esophagitis: Improving Outcomes in Pediatric and Adult Patients Through Earlier Diagnosis and Treatment – An Innovative Whiteboard View

FACULTY


Matthew Greenhawt, MD
Associate Professor of Pediatrics
Director, Food Challenge and Research Unit
Children’s Hospital Colorado
University of Colorado School of Medicine
Aurora, CO

Ikuo Hirano, MD
Professor of Medicine
Division of Gastroenterology and Hepatology
Northwestern University Feinberg School of Medicine
Chicago, IL

PROGRAM OVERVIEW

This case-based activity will cover the epidemiology, pathophysiology, diagnosis, and treatment of eosinophilic esophagitis.


TARGET AUDIENCE

This educational activity is designed to meet the educational needs of gastroenterologists, allergists, immunologists, pediatric gastroenterologists, pediatric allergists, pediatric immunologists, and specialty NPs and PAs involved in the treatment of adult and pediatric patients with eosinophilic esophagitis.


LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

  • Promptly and accurately diagnose eosinophilic esophagitis (EoE) based on the clinical and histologic presentation of EoE in pediatric and adult patients
  • Evaluate the mechanism of action, efficacy and safety of emerging agents that target the underlying inflammation in EoE
  • Develop treatment plans that promptly initiate therapy in patients with EoE to reduce the risk of disease progression and improve quality of life

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.


CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.


NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the treatment of patients with Eosinophilic Esophagitis.
Credits: 1.0 ANCC Contact Hour.


CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.


COMMISSION ON DIETETIC REGISTRATION

This program has received prior approval with the Commission on Dietetic Registration for dietitians and RDs.


DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Greenhawt is a consultant for Aquestive. He serves on Advisory Boards for Intrommune, Nutricia, DBV, Novartis, Pfizer, Sanofi/Genzyme, Prota, Allergenis, Aquestive, US WorldMeds, and Allergy Therapeutics. He also has participated in speaking engagements for DBV. His non-financial relationships include: Member of Joint Task Force on Allergy Practice Parameters, CSACI Food Allergy in Schools Guideline Panel, the Medical Advisory team for the Allergy and Asthma Foundation of America and the International Association for Food Protein Enterocolitis, AAAAI PDT, Anaphylaxis, Adverse Reaction to Food committees, NIAID Expert Panel on early introduction of peanut to prevent peanut allergy, Scientific Advisory Council, National Peanut Board, EAACI Task Force on Nutrition and Immunomodulation; Food Immunotherapy Outcomes Taskforce; Parental Perception of Allergic Diseases and Impact of Social Networks Taskforce, Co-Chair AAAAI Primary Prevention of Food Allergy Working Group; Co-chair, AAAAI Oral Immunotherapy Office-based Practice Working Group, and editorial board member of Pediatric Allergy and Immunology; Infectious Diseases in Children. Member ACAAI Annual Meeting Planning Committee, Chair, GI/Food Allergy Track chair; Chair, Food Allergy Committee; Member Scientific council; Member Young Faculty Award Committee

Dr. Hirano has received consulting fees from Adare, Allakos, Arena, AstraZeneca, Eli Lilly, Gossamer, Receptos/Celgene, Regeneron and Shire/Takeda. He has also been on the speakers bureau for Takeda.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

Staff, Planners, and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Cindy Lampner, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Ashley Whitehurst, Program Manager for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.


DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.


METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the activity.
  3. Complete pre-and-post surveys and evaluation.

You will receive your certificate as a downloadable file.


DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

RELEASE DATE: June 16, 2021

EXPIRATION DATE: June 16, 2022

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com.

Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.